New Zealand Medical Device Regulations

Regulatory Agency

Medical Device Definition

Medical Device:

а) means any device, instrument, apparatus, appliance, or other article that -

i. is intended to be used in, on, or for human beings for a therapeutic purpose; and

ii. does not achieve its principal intended action in or on the human body by pharmacological, immunological, or metabolic means (but may be assisted in its function by such means); and

b)   includes a material that -

i.    is intended to be used in or on human beings for a therapeutic purpose; and

ii.   does not achieve its principal intended action in or on the human body by pharmacological, immunological, or metabolic means (but may be assisted in its function by such means); and

c) also includes -

i. anything that is intended to be used with a device, instrument, apparatus, appliance, article, or material referred to in paragraph (a) or (b) to enable the device, instrument, apparatus, appliance, article, or material to be used as its manufacturer intends; and

ii. any device, instrument, apparatus, appliance, article, or material of a kind or belonging to a class that is declared by regulations to be a medical device for the purposes of the Medicines Act; but

d) does not include a device, instrument, apparatus, appliance, article, or material of a kind or belonging to a class that is declared by regulations not to be a medical device for the purposes of the Medicines Act.

Active Implantable Medical Device or AIMD means an active medical device that is intended by the manufacturer:
* Either-
   * to be introduced wholly, or partially, into the human body by surgical or medical intervention; or
   * to be introduced into a natural orifice in the human body by medical intervention; and
* To remain in place after the procedure


Active Medical Device:
(a) means a medical device that is intended by the manufacturer-
(i) to depend for its operation on a source of electrical energy or other sources of energy (other than a source of energy generated directly by a human being or gravity); and
(ii) to act by converting that energy; but
(b) does not include a medical device that is intended by the manufacturer to transmit energy, a substance, or any other element, between a medical device to which paragraph (a) applies and a human being without any significant change in the energy, substance, or other element being transmitted.

Medical Device Classification System

International Classification Risk Level Examples
Class I basic Low Risk Reusable surgical instruments
Class I measuring Low Risk Volumetric urine bag
Class I sterile Low Risk Sterile dressings, non-medicated
Class IIa Low–moderate risk Hypodermic needles, suction equipment
Class IIb Medium-high risk Ventilators, orthopedic implants
Class III & Active implantable medical device(AIMD) High risk Drug-eluting cardiac stents, Implantable pacemaker

Regulatory Approval Process

Classification Approval procedure
Class I
  • -If you do not have a physical presence in New Zealand, appoint a local Sponsor who has a registered business or principal place of business in Zealand.
  • -No technical dossier is submitted for WAND listing. However, the device risk classification, GMDN code, intended purpose of the device, and supporting documentation for safety and effectiveness must be established.
  • -Sponsor lodges a new Manufacturer Notification. Processing takes up to 5 business days.
  • -Sponsor enters the medical device information (including classification and GMDN code) into the WAND database. If available, the Australian Register of Therapeutic Goods (ARTG) registration number may be provided (optional). There are no government fees associated with WAND notifications, and there is no review/approval process.
  • -Begin marketing the device in New Zealand. Maintain the correctness and completeness of the device information in WAND.
Class IIa
Class IIb
Class III
Additional Information
Approval timeline within 30 days of commercialization.
License validity period N/A
Fees All information is submitted free of charge to the WAND database.

#WednesdayWebinar Join us for our upcoming webinar Global Regulatory Changes to Expect in 2025 January 22, 2025 at 10 AM ET

Register Now